CLOV vs DNTH
Clover Health Investments Corp (CLOV) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CLOV currently screens at market cap $1.55B. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CLOV and DNTH stock pages for the full models.
Not investment advice.